Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BOSUTINIB for Chronic myeloid leukaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 4,231 adverse event reports in the FDA FAERS database where BOSUTINIB was used for Chronic myeloid leukaemia.

Most Reported Side Effects for BOSUTINIB

Side Effect Reports % Deaths Hosp.
Diarrhoea 1,820 23.4% 76 324
Nausea 886 11.4% 31 165
Fatigue 626 8.1% 33 136
Vomiting 469 6.0% 27 122
Death 465 6.0% 459 62
Rash 426 5.5% 7 70
Pleural effusion 398 5.1% 20 160
Neoplasm progression 376 4.8% 34 44
Dyspnoea 319 4.1% 20 133
Headache 283 3.6% 8 55
Drug intolerance 277 3.6% 6 24
Malaise 272 3.5% 12 68
Off label use 265 3.4% 13 46
Abdominal pain 234 3.0% 12 67
Arthralgia 218 2.8% 5 47

Other Indications for BOSUTINIB

Product used for unknown indication (350) Leukaemia (191) Philadelphia positive chronic myeloid leukaemia (101) Acute lymphocytic leukaemia (89) Myeloid leukaemia (83) Neoplasm malignant (59) Chronic myeloid leukaemia (in remission) (56) Philadelphia chromosome positive (53) Acute myeloid leukaemia (50) Chronic lymphocytic leukaemia (36)

Other Drugs Used for Chronic myeloid leukaemia

IMATINIB (18,795) DASATINIB (15,612) NILOTINIB (14,842) PONATINIB (4,723) ASCIMINIB (1,377) GLIVEC (636) TASIGNA (562) OMACETAXINE MEPESUCCINATE (500) HYDROXYUREA (457) CYTARABINE (241)

Related Pages

BOSUTINIB Full Profile All Chronic myeloid leukaemia Drugs BOSUTINIB Demographics BOSUTINIB Timeline